The trademark Myhaevyn was filed by CSL Behring GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on January 30, 2023, and received one opposition filed on April 30, 2023 by Biohaven Therapeutics Ltd. on Likelihood of confusion. the opponent was represented by Arnesen IP Advokatfirma and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued April 30, 2023
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).